Deans' stroke musings: Endovascular Therapy for Medium-Vessel Occlusion Stroke

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, May 29, 2026

Endovascular Therapy for Medium-Vessel Occlusion Stroke — Narrowing the Target Population

Don't you know the goal is to leave no survivor behind AND provide EXACT 100% recovery protocols? Or did your mentors and senior researchers incompetently fail to tell you about survivor goals? NOT YOUR DOCTOR OR THERAPISTS GOALS!

Endovascular Therapy for Medium-Vessel Occlusion Stroke — Narrowing the Target Population

Authors: Johanna M. Ospel, M.D., Ph.D., and Michael D. Hill, M.D. https://orcid.org/0000-0002-6269-1543Author Info & Affiliations

Published May 13, 2026

N Engl J Med 2026;394:1955-1957

DOI: 10.1056/NEJMe2601852

VOL. 394 NO. 19

Abstract

One way to classify acute ischemic stroke is by the anatomy of vessel occlusion. Initial randomized trials of endovascular thrombectomy focused on large-vessel occlusions.^1-5 These proximal occlusions of the intracranial carotid artery or the stem of the middle cerebral artery (MCA) represent the most severe form of anterior circulation ischemic stroke. The large clinical benefit from endovascular thrombectomy is consistent with the patent artery hypothesis and reperfusion associated with intravenous thrombolysis. Reperfusion success after endovascular thrombectomy is now routinely achieved in 90% of patients, but early reperfusion, as measured with computed tomographic (CT) angiography at approximately 2 to 4 hours . . .